Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease von Kashukh, E. A., Poluektova, E. A., Kudryavtseva, A. V., Krasnov, G. S., Kazey, V. I., Sobolev, P. D., Gremyakova, P. V., Ivashkin, V. T.

Volltext